HNF1A and hepatocellular adenoma: It is known that long-term use of OCPs is strongly linked to the development of HCAs; for example, 88% of cases of hepatocyte nuclear factor 1alpha (HNF1A)-mutated HCA (H-HCA) and 77% of cases of I-HCA are women taking OCPs [8].